Ignite Creation Date:
2024-05-05 @ 10:53 PM
Last Modification Date:
2024-10-26 @ 10:25 AM
Study NCT ID:
NCT01202487
Status:
COMPLETED
Last Update Posted:
2013-04-10
First Post:
2010-09-14
Brief Title:
Gluing Lacerations Utilizing Epinephrine
Sponsor:
Childrens Hospital of Eastern Ontario
Organization:
Childrens Hospital of Eastern Ontario
Study Overview
Official Title:
Pretreatment of Lacerations With Topical LET Lidocaine-Epinephrine-Tetracaine Reduces Pain During Tissue Adhesive Repair in Children Double-blind Randomized Controlled Trial of Efficacy
Status:
COMPLETED
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GLUE
Brief Summary:
Minor lacerations are a commonly treated injury in the paediatric emergency department Over the past decade standard closure of these lacerations has evolved from suture repair to closure with tissue adhesive also referred to as skin glue Local anaesthetic is not routinely used during application of skin glue as it was with sutures There are however several potential advantages to pre-treating wounds with topical LET Lidocaine-Epinephrine-Tetracaine a liquid gel with anaesthetic and vasoconstrictive properties Some believe LET can improve patient comfort increase the ease of glue application and lead to better healing when used on lacerations being repaired with tissue adhesive This study aims to address the question of whether or not pre-treatment with LET improves outcomes in minor lacerations repaired with skin glue The primary hypothesis is that pre-treatment of minor lacerations with LET will decrease pain as measured on a Visual Analog Scale during repair with tissue adhesive
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None